Pharmaceutical preformulation is a crucial phase in drug development that focuses on understanding the physical and chemical properties of potential drug candidates before they advance to formulation. This initial stage plays a pivotal role in optimizing drug design, ensuring stability, and predicting how the drug will behave in various dosage forms.
During pharmaceutical preformulation, researchers investigate key parameters such as solubility, stability, and compatibility of the drug with excipients. These studies help in selecting the most suitable form of the drug for further development. Additionally, preformulation studies assess factors like particle size, crystallinity, and polymorphism, influencing the drug's bioavailability and overall efficacy. This proactive approach minimizes the risk of unexpected challenges during later stages of drug development and contributes to the overall success of pharmaceutical formulations.
In essence, pharmaceutical preformulation lays the foundation for informed decision-making, enabling researchers to navigate the complex landscape of drug development with a comprehensive understanding of the physical and chemical attributes of potential therapeutic agents.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico